NEW YORK (GenomeWeb News) – The National Cancer Institute said today that it has struck an agreement with a South Korean hospital to partner on the development and application of proteomic tools in a clinical environment.

NCI's Office of Cancer Clinical Proteomics Research (OCCPR) and Seoul National University Cancer Hospital (SNUCH) have inked a memorandum of understanding under which SNUCH will test proteomic technologies, standards, workflows, and protein assays developed by NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC).

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.

Oct
10
Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.